Page last updated: 2024-09-02

3,5-dihydroxyphenylglycine and eticlopride

3,5-dihydroxyphenylglycine has been researched along with eticlopride in 1 studies

Compound Research Comparison

Studies
(3,5-dihydroxyphenylglycine)
Trials
(3,5-dihydroxyphenylglycine)
Recent Studies (post-2010)
(3,5-dihydroxyphenylglycine)
Studies
(eticlopride)
Trials
(eticlopride)
Recent Studies (post-2010) (eticlopride)
301161378195

Protein Interaction Comparison

ProteinTaxonomy3,5-dihydroxyphenylglycine (IC50)eticlopride (IC50)
D(2) dopamine receptorMus musculus (house mouse)0.0009
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0009

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Albin, RL; Frey, KA; Kearney, JA1

Other Studies

1 other study(ies) available for 3,5-dihydroxyphenylglycine and eticlopride

ArticleYear
Metabotropic glutamate agonist-induced rotation: a pharmacological, FOS immunohistochemical, and [14C]-2-deoxyglucose autoradiographic study.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1997, Jun-01, Volume: 17, Issue:11

    Topics: Animals; Autoradiography; Basal Ganglia; Behavior, Animal; Caffeine; Carbon Radioisotopes; Cycloleucine; Deoxyglucose; Dopamine; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Glucose; Glycine; Immunohistochemistry; Male; Neuroprotective Agents; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Receptors, Muscarinic; Receptors, Purinergic P1; Resorcinols; Rotation; Salicylamides; Thalamic Nuclei; Xanthines

1997